Three drug companies recalled 126 lots of the blood pressure drugs losartan and valsartan this ... AurobindoPharma recalled 40 mg, 80 mg, 160 mg and 320 mg tablets that were distributed to ...

Lawyers for consumers who claim harm from tainted versions of the blood pressure-lowering drug valsartan want to expand litigation to include at least two other drugs, losartan and irbesartan.

That new could-be carcinogen, N-Methylnitrosobutyric acid (NMBA), caused Camber Pharmaceuticals to recall an additional 87 lots of Losartan potassium tablets Thursday. Friday, Torrent recalled 60 ...

Andersson and Neldam [5] evaluated candesartan cilexetil 8 and 16 mg vs. losartan 50 mg and found that candesartan cilexetil 16 mg once daily (n=84) reduced trough DBP more effectively than ...

Drug repackager Legacy Pharmaceutical Packaging is recalling 40 repackaged lots of Losartan Tablets USP 25 mg, 50 mg and 100 mg to the consumer level because they were made with an API in which ...

A total of 1513 patients were enrolled in this randomized, double-blind study comparing losartan (50 to 100 mg once daily ... accounting for approximately 40 percent of all cases in the United ...

In conclusion, losartan 50 mg o.d. and enalapril 20 mg o.d. lower BP to approximately the same extent, except for a more pronounced effect of enalapril on daytime ambulatory BP. The current ...

losartan in 654 hypertensive patients with a diastolic blood pressure between 95 and 114 mm Hg from 72 sites throughout the U.S. Eligible patients were randomized to candesartan cilexetil 16 mg ...